These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1391949)

  • 1. No correlation between the type of bcr-abl hybrid messenger RNA and platelet counts in chronic myelogenous leukemia.
    Opalka B; Wandl UB; Stutenkemper R; Kloke O; Seeber S; Niederle N
    Blood; 1992 Oct; 80(7):1854-5. PubMed ID: 1391949
    [No Abstract]   [Full Text] [Related]  

  • 2. Possible correlation of b3-a2-type bcr-abl messenger RNA defined by semiquantitative RT-PCR to platelet and megakaryocyte counts in Philadelphia-positive chronic myelogenous leukemia.
    Inokuchi K; Futaki M; Dan K; Nomura T
    Intern Med; 1994 Apr; 33(4):189-92. PubMed ID: 7520786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A possible correlation between the type of bcr-abl hybrid messenger RNA and platelet count in Philadelphia-positive chronic myelogenous leukemia.
    Inokuchi K; Inoue T; Tojo A; Futaki M; Miyake K; Yamada T; Tanabe Y; Ohki I; Dan K; Ozawa K
    Blood; 1991 Dec; 78(12):3125-7. PubMed ID: 1742479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular breakpoints and platelet counts in chronic myeloid leukemia.
    Shepherd PC; Bond C; Allan NC
    Blood; 1992 Jul; 80(2):556-7. PubMed ID: 1378324
    [No Abstract]   [Full Text] [Related]  

  • 5. The relationship between the type of bcr-abl hybrid messenger RNA and thrombopoiesis in Philadelphia-positive chronic myelogenous leukemia.
    Inokuchi K; Nomura T
    Leuk Lymphoma; 1993 May; 10(1-2):9-15. PubMed ID: 8374529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic myeloid leukemia with e19a2 (c3a2) BCR/ABL fusion junction--is it truly a benign disease?
    How GF; Tan LT; Lim LC
    Leukemia; 1998 Jul; 12(7):1166-7. PubMed ID: 9665206
    [No Abstract]   [Full Text] [Related]  

  • 7. Elevated platelet count features the variant type of BCR/ABL junction in chronic myelogenous leukaemia.
    Yamagata T; Mitani K; Kanda Y; Yazaki Y; Hirai H
    Br J Haematol; 1996 Aug; 94(2):370-2. PubMed ID: 8759898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The differences and correlations of BCR-ABL transcripts between peripheral blood and bone marrow assays are associated with the molecular responses in the bone marrow for chronic myelogenous leukemia.
    Jiang Q; Zhao XY; Qin YZ; Liu YR; Lai YY; Jiang B; Huang XJ
    Am J Hematol; 2012 Dec; 87(12):1065-9. PubMed ID: 22965919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chronic myelocytic cell line K 562 contains minor (m) as well as major (M) ber/abl fusion mRNAs.
    Seelig R; Schranz P; Bottner C; Neubauer A; Seelig HP; Renz M
    Leukemia; 1993 Nov; 7(11):1886-7. PubMed ID: 8231257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of p210 BCR-ABL transcript variants with clinical, parameters and disease outcome in 45 chronic myeloid leukemia patients.
    Al-Achkar W; Moassass F; Youssef N; Wafa A
    J BUON; 2016; 21(2):444-9. PubMed ID: 27273956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCR/ABL mRNA and the P210(BCR/ABL) protein are downmodulated by interferon-alpha in chronic myeloid leukemia patients.
    Pane F; Mostarda I; Selleri C; Salzano R; Raiola AM; Luciano L; Saglio G; Rotoli B; Salvatore F
    Blood; 1999 Oct; 94(7):2200-7. PubMed ID: 10498589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABL-BCR mRNAs transcribed from chromosome 9q+ in Philadelphia-chromosome-positive chronic myeloid leukaemia.
    MacKenzie E; Stewart E; Birnie GD
    Leukemia; 1993 May; 7(5):702-6. PubMed ID: 8483322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by polymerase chain reaction.
    Sawyers CL; Timson L; Kawasaki ES; Clark SS; Witte ON; Champlin R
    Proc Natl Acad Sci U S A; 1990 Jan; 87(2):563-7. PubMed ID: 2405384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of bcr-abl gene rearrangement detected by polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia.
    Delage R; Soiffer RJ; Dear K; Ritz J
    Blood; 1991 Nov; 78(10):2759-67. PubMed ID: 1824268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribozyme-mediated cleavage of the bcr/abl transcript expressed in chronic myeloid leukemia.
    Wright L; Wilson SB; Milliken S; Biggs J; Kearney P
    Exp Hematol; 1993 Dec; 21(13):1714-8. PubMed ID: 8243570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consistent amounts of acute leukemia-associated P190BCR/ABL transcripts are expressed by chronic myelogenous leukemia patients at diagnosis.
    Saglio G; Pane F; Gottardi E; Frigeri F; Buonaiuto MR; Guerrasio A; de Micheli D; Parziale A; Fornaci MN; Martinelli G; Salvatore F
    Blood; 1996 Feb; 87(3):1075-80. PubMed ID: 8562932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Typical chronic myelogenous leukemia with e19a2 junction BCR/ABL transcript.
    Briz M; Vilches C; Cabrera R; Forés R; Fernández MN
    Blood; 1997 Dec; 90(12):5024-5. PubMed ID: 9389724
    [No Abstract]   [Full Text] [Related]  

  • 18. A nested RT-PCR assay to detect BCR/abl.
    Wasserman LM
    Methods Mol Med; 2004; 97():181-9. PubMed ID: 15064493
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of bcr/c-abl mRNA in chronic myelogenous leukemia by polymerase chain reaction to identify chromosome translocation.
    Lin CP; Chen PM; Yen JS; Wang RL; Lee LS; Chen PH; Chang JG
    J Formos Med Assoc; 1992 Mar; 91(3):247-51. PubMed ID: 1354683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of reverse BCR/ABL gene rearrangement in Ph-negative chronic myelogenous leukemia.
    Verma RS; Chandra P
    Leuk Res; 2000 Jul; 24(7):631-5. PubMed ID: 10867140
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.